Straumann Holding AG (FRA:QS51) Common Stock : €2 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Straumann Holding AG Common Stock?

Straumann Holding AG's quarterly common stock increased from Dec. 2022 (€2 Mil) to Jun. 2023 (€2 Mil) and increased from Jun. 2023 (€2 Mil) to Dec. 2023 (€2 Mil).

Straumann Holding AG's annual common stock increased from Dec. 2021 (€2 Mil) to Dec. 2022 (€2 Mil) and increased from Dec. 2022 (€2 Mil) to Dec. 2023 (€2 Mil).

Straumann Holding AG Common Stock Historical Data

The historical data trend for Straumann Holding AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG Common Stock Chart

Straumann Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

1.46

1.47

1.53

1.62

1.69

Straumann Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Common Stock	Get a 7-Day Free Trial															1.53	1.55	1.62	1.64	1.69

Straumann Holding AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Straumann Holding AG (FRA:QS51) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS51) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

SAUHY:USA SAUHF:USA STMNz:UK 0QMV:UK STMN:Switzerland

Address

Peter Merian-Weg 12, Basel, CHE, 4002

Website

https://www.straumann-group.com

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (FRA:QS51) Headlines

No Headlines